Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

InflaRx N.V. - Common Stock (NQ: IFRX )

1.300 -0.020 (-1.52%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 86,658
Open 1.300
Bid (Size) 1.150 (106)
Ask (Size) 1.500 (5)
Prev. Close 1.320
Today's Range 1.300 - 1.350
52wk Range 0.8238 - 2.815
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Carnival To Rally Over 50%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Earnings Scheduled For March 20, 2025
Via Benzinga

Performance

YTD
-48.00%
-48.00%
1 Month
+4.84%
+4.84%
3 Month
-44.44%
-44.44%
6 Month
-17.20%
-17.20%
1 Year
-6.47%
-6.47%

More News

Read More
Earnings Preview: InflaRx
Via Benzinga
Earnings Preview: InflaRx
Via Benzinga
Why InflaRx Stock Skyrocketed This Week
Via The Motley Fool
Infinitum: Pioneering Quantum-Proof Blockchain Solutions to Transform Finance
Via ACCESS Newswire
Friday's session: top gainers and losers
Via Chartmill
What's going on in today's session
Via Chartmill
Friday's session: gap up and gap down stocks
Via Chartmill
Analyst Expectations for InflaRx's Future
Via Benzinga
Top movers in Friday's pre-market session
Via Chartmill
Get insights into the top gainers and losers of Thursday's after-hours session.
Via Chartmill
IFRX Stock Earnings: InflaRx Misses EPS, Misses Revenue for Q2 2024
Via InvestorPlace
IFRX Stock Earnings: InflaRx Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
IFRX Stock Earnings: InflaRx Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Earnings Scheduled For March 21, 2024
Via Benzinga
Why Tellurian Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
Via Benzinga
InflaRx Announces Initiation of its Commitment Program for GOHIBIC®(vilobelimab) to Help Broaden Access for Eligible Patients
From InflaRx N.V.
Via GlobeNewswire
Why DigitalOcean Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
Why Oncorus Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
Via Benzinga
The Week In Charts: 0DTE Options - Too Good To Be True?
Via Talk Markets
Apogee Enterprises, Sportsman's Warehouse And 3 Stocks To Watch Heading Into Wednesday
Via Benzinga
Post-Pandemic Potential: Analysts Eye InflaRx COVID-19 Antibody For Market Breakthrough
Via Benzinga
Walmart To Rally 14%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.